ERELZI SensoReady 50 mg/ml 12 stylo pré 1 ml

7680661760043 CH-66176 L04AB01 07.15.0.

Reimbursement limitations:

ERELZI2

Substitution préparation de référence/biosimilaire
Traitement par ERELZI exige une garantie préalable de prise en charge …

ERELZI SensoReady 50 mg/ml 12 stylo pré 1 ml
ERELZI SensoReady 50 mg/ml 12 stylo pré 1 ml
ERELZI SensoReady 50 mg/ml 12 stylo pré 1 ml
1 / 3
google

Details

Product number
6617601
CPT
-
Packaging group
12
Unit
Injektor(en), vorgefüllt/Pen
Composition
etanerceptum 50 mg, acidum citricum, natrii citras dihydricus, natrii chloridum, saccharum, lysini hydrochloridum, natrii hydroxidum aut acidum hydrochloridum 25 per centum, aqua ad iniectabile q.s. ad solutionem pro 1 ml corresp. natrium 3.76 mg.

Articles (1)

Erelzi SensoReady 50 mg/1 ml, Injektionslösung im Fertigpen
Injektionslösung im Fertigpen
12
View

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
16/01/2025
Patient information leaflet
Français
16/01/2025
Patient information leaflet
Italien
16/01/2025

Detailed composition

Substance Quantity Type Category
(N/A)
50.0 MG Substance Wirkstoff (Principe actif)
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
3.76 MG Substance HBESI

Authorization holder

Sandoz Pharmaceuticals AG

6343 Risch

Authorization information

Swissmedic authorization number
66176
Drug name
Erelzi SensoReady, Injektionslösung im Fertigpen
Galenic form
LSPA
ATC Code
L04AB01
Authorization status
Z
Dispensation category
B
First authorization
18/05/2018
Authorization expiration date
31/12/9999
IT number
07.15.0.
Domain
Human medicine
Field of application
Rheumatoide Arthritis, juvenile idiopatische Arthritis (Polyarthritis, Oligoarthritis, Psoriasis-Arthritis, Enthesitis-assoziierte Arthritis), Psoriasis-Arthritis, Morbus Bechterew (ankylosierende Spondylitis), mittelschwere bis schwere Plaque-Psoriasis

Packaging details

Description (FR)
ERELZI SensoReady 50 mg/ml 12 stylo pré 1 ml
Description (DE)
ERELZI SensoReady 50 mg/ml 12 Fertpen 1 ml
Market launch
18/05/2018
Narcotic (BTM)
No

Other packaging sizes

ERELZI SensoReady 50 mg/ml stylo pré 1 ml
1 INJ
View
ERELZI SensoReady 50 mg/ml 2 stylo pré 1 ml
2 INJ
View
ERELZI SensoReady 50 mg/ml 4 stylo pré 1 ml
4 INJ
View